Literature DB >> 14598611

Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.

Antigony Mitselou1, Elli Ioachim, Evagelia Kitsou, Theodore Vougiouklakis, Nektaria Zagorianakou, Georgios Makrydimas, Stella Stefanaki, Niki J Agnantis.   

Abstract

The bcl-2 gene codes for a protein which functions to inhibit apoptotic cell death, that involves an intrinsic normal cell death program. Bcl-2 overexpression was originally described in a follicular lymphoma, but more recently bcl-2 expression has been observed in a variety of other human neoplasms. Variation in the frequency of apoptosis in hormone-sensitive tissues, such as the endometrium, is known to occur as a result of hormonal changes in both physiological and pathological circumstances. In this study we examined bcl-2 protein expression in a total of 170 samples of endometrial tissues (18 proliferative endometrium, 14 secretory endometrium, 35 adenomatous hyperplasia and 103 carcinomas). The results were compared with p53, pRb and c-erbB-2 proteins expression, estrogen and progesterone receptors status, with the proliferative activity and with clinicopathological features. The expression of bcl-2 protein was lower in the group of carcinomas, when compared with the cases of adenomatous hyperplasia (p < 0.0001), normal proliferative (p < 0.0001) and secretory endometrium (p = 0.07). In normal proliferative endometrium bcl-2 expression was correlated with PCNA (p = 0.026) and in secretory endometrium it was correlated with ER status (p = 0.042). In hyperplasias, bcl-2 was correlated with PCNA (p = 0.019) and the PR (p = 0.007) expression. In carcinomas, decreased bcl-2 expression was associated with increased tumor grade (p = 0.04). A positive relationship between bcl-2 expression and pRb, as well as PCNA score (p = 0.014 and p = 0.001, respectively), was also found. These results indicate that bcl-2 expression may play a role in the inhibition of apoptosis in endometrial carcinoma and its expression seems to be associated with tumor differentiation and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598611

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

1.  Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.

Authors:  A Z Balta; A I Filiz; Y Kurt; I Sucullu; E Yucel; M L Akin
Journal:  Med Oncol       Date:  2011-05-06       Impact factor: 3.064

2.  Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures--a pilot study.

Authors:  Ariane Germeyer; Michael von Wolff; Julia Jauckus; Thomas Strowitzki; Tanuj Sharma; Anna T Grazul-Bilska
Journal:  Reprod Biol Endocrinol       Date:  2010-06-21       Impact factor: 5.211

3.  RNA interference of pax2 inhibits growth of transplanted human endometrial cancer cells in nude mice.

Authors:  Li-Ping Zhang; Xiao-Yan Shi; Chang-Yin Zhao; Yong-Zhen Liu; Ping Cheng
Journal:  Chin J Cancer       Date:  2011-06

Review 4.  New concepts for an old problem: the diagnosis of endometrial hyperplasia.

Authors:  Peter A Sanderson; Hilary O D Critchley; Alistair R W Williams; Mark J Arends; Philippa T K Saunders
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

5.  Immunohistochemical features of a papillary squamous cell carcinoma of the endometrium with transitional cell differentiation.

Authors:  Alfredo Ribeiro-Silva
Journal:  Diagn Pathol       Date:  2007-07-23       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.